32
total announcements
AMANTA.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 15 Oct 2026
Market Cap
₹716 Cr
P/E (TTM)
44.3
EPS (TTM)
₹4.16
52W Low
₹92.00
52W High
₹209.95
Dividend Yield
0.00%
Price / Book
2.9
Debt / Equity
111.0
Revenue (TTM)
₹291 Cr
Gross Margin
65.94%
Operating Margin
14.32%
Amanta Healthcare Limited
Amanta Healthcare Limited has submitted a statement of deviation or variation in utilization of funds raised through its IPO for the quarter ended June 30, 2026, as per Regulation 32 of the SEBI Listing Regulations. The company confirms that there has been no deviation or variation in the use of proceeds of funds raised through Public Issue.
Amanta Healthcare Limited
Amanta Healthcare Limited has submitted its financial results for the quarter ended June 30, 2026, and has approved the appointment of a scrutinizer for its upcoming Annual General Meeting.
Amanta Healthcare Limited
Amanta Healthcare Limited has informed the Exchange about change in Senior Management Personnel of the Company, with the inclusion of Mr. Nilesh Punjabi as Senior Management Personnel (SMP) as Assistant Vice President (HR & Admin).
Amanta Healthcare Limited
Amanta Healthcare Limited has scheduled an analyst/investor conference call to discuss Q1 FY27 financial performance and business updates on August 6, 2026.
Amanta Healthcare Limited
Amanta Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018.
Amanta Healthcare Limited
Amanta Healthcare Limited has informed the Exchange about the outcome of its Investor/Analyst Meeting, where officials interacted with investors and analysts on July 9, 2026. The meeting was virtual, and no unpublished price sensitive information (UPSI) was discussed or shared.
Amanta Healthcare Limited
Amanta Healthcare Limited has informed the Exchange about the schedule of an investor/analyst meeting on July 9, 2026, with ValPro Capital.
Amanta Healthcare Limited
Amanta Healthcare Limited has submitted disclosures under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, regarding an off-market transfer of equity shares.
Amanta Healthcare Limited
Amanta Healthcare Limited has informed the Exchange about a copy of Newspaper Publication regarding a special window for transfer and dematerialization requests of physical shares.
Amanta Healthcare Limited
Amanta Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Amanta Healthcare Limited
Amanta Healthcare Limited has announced the receipt of a disclosure from Shri Bhavesh Girishbhai Patel, one of its promoters. This intimation, filed under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, confirms an open-market purchase of the company's equity shares by the promoter. Such an action typically signals confidence by the promoter in the company's future prospects and valuation.
Amanta Healthcare Limited
Amanta Healthcare Limited has informed the Exchange regarding 'Intimation under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015'. The company has received a declaration under Regulation 7(2) from one of its promoters, Shri Bhavesh Girishbhai Patel, regarding open-market purchase of equity shares.